Basket

  Untick selected:   0
  1. Nefroprotektivita SGLT-2 inhibítorov - ďalší dôkaz podáva kanagliflozín v štúdii CREDENCE = Nephroprotecitivity of SGLT2 inhibitors - next confirmation is given with cnagliflozin in CREDENCE trial / Ján Murín ... [et al.]. Interná medicína Roč. 19, č. 9 (2019), s. 330-331
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.